A new independent study finds that Maryland has built “one of the nation’s strongest life sciences industries” that directly employs more than 54,000 workers in the state. The report from the globally recognized Milken Institute also identifies new opportunities for the public and private sectors to enhance Maryland’s entrepreneurial ecosystem and to strengthen its workforce development strategies.
What’s up, everybody? My name’s Jake Greenwood and if you’re not aware, I have a weekly segment on LinkedIn called #WannaGoWednesday where I highlight upcoming Life Sciences Industry events in the BioHealth Capital Region and beyond. Very often I’m looking at BioBuzz to see what those upcoming events might be. Well, the good folks leading the community at BioBuzz have invited me to invade their platform and share the can’t miss events for the remainder of 2021.
TEDCO Talks’, a video series launched by TEDCO in November 2020, serves as a platform for individuals to hear from thought leaders on economic development in the BioHealth Capital Region (BHCR), and particularly in Maryland. These 30-minute virtual ‘fireside chats’ cover a range of topics, such as advice to small businesses dealing with COVID-19, available funding programs and benefits, diversity and inclusion, and more.
Congressman David Trone (MD-06) and Deputy Secretary of Commerce Don Graves toured Kite Pharma with the Maryland Tech Council on Friday.
The BioHealth Capital Region (BHCR) has been witnessing a strong upward growth trajectory in recent years. The COVID-19 pandemic has only heightened the need for increased research, diagnostic and domestic manufacturing needs in the region. But while workforce needs are in demand, the right skills are in short supply.
A few weeks ago, we wrote about how the BioHealth Capital Region’s (BHCR) biotech sector is booming. Advanced biomanufacturing, cell and gene therapy, vaccine development, and the medtech industries have all seen record growth over the past few years.
When the Biotechnology Innovation Organization (BIO) convenes its annual trade show this month, Maryland’s life sciences ecosystem, which played a significant role in combating the global COVID-19 pandemic, will be on full display.
Novavax trials highlight Maryland’s COVID-fighting complex When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers [….]
StroMel™ is a proprietary adipose-derived Stromal Vascular Fraction (SVF) product. StroMel™ will be frozen and stored allowing multiple administrations with each lot. Although the current IND is for autologous administration, Akan is planning to explore allogeneic applications as well.
The COVID-19 pandemic has presented no shortage of challenges for Maryland businesses from managing a remote workforce to accessing volatile capital markets. The Maryland Tech Council (MTC) believes local companies can turn these challenges into long-term opportunities.
